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Background
The past few decades have been marked by an ever-
increasing awareness of bioethical issues among the scien-
tific community and general public. Informed consent is
a question of central importance in contemporary medi-
cal ethics, and clinical practice is inconceivable without
considering the issues it raises. The determination of psy-
chiatric patient's capacity to understand the risks and ben-
efits of participation in clinical research trials remains an
important and controversial issue among psychiatric
research community. The purpose of this study is to sum-
marize and critically present the challenges and moral
parameters arising from the assessments of the ability of
individuals with impaired cognitive function to give
informed consent for clinical research enrollment.
Materials and methods
A literature search from 1991 to 2007 was carried out
using the ScienceDirect, and Medline electronic data-
bases. The identified research studies were further exam-
ined and synthesized.
Results
Recent research indicates that although certain psychiatric
disorders might place patients at increased risk of being
unable to provide informed consent, psychiatric diagnosis
alone does not adversely affect the capacity to consent to
research. Decision-making capacity for research is not
general but should be viewed as situation specific. Many
studies argue that there should be a clear distinction
between severity of cognitive deficits and severity of disor-
der's symptoms. A number of factors such as cultural and
religious values, external pressures and developmental
factors often escape attention of the researchers, and have
not yet formed a systematic element of research interest.
Intervention (e.g. presentation method, educational pro-
cedures etc) seem to improve understanding and decision
-making ability. The currently used scales providing help
in assessing competence in clinical practice and their eval-
uation are also discussed in our study.
Conclusions
The issue of informed consent has been the object of dis-
cussion and disagreement from many perspectives, which
are not limited only to the field of medicine. Investigators
with mental impaired participants have a greater respon-
sibility for building appropriate safeguards. The inappro-
priate exclusion of competent individuals may suggest a
paternalistic intervention against patient's autonomy and
free will. The need for balance between the protection of
the psychiatric patient and the necessity to develop effi-
cient and safe drugs proposes a framework that does not
just pursue legal immunity but describes a more general
moral attitude and scientific mentality.
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